Search For Lab Tests Here

The Glucose Tolerance Test, 5 Specimens evaluates glucose response at fasting, 1, 2, 3, and 4 hours after a standard glucose drink. By analyzing multiple specimens, it identifies impaired glucose tolerance, prediabetes, and type 2 diabetes. The test provides clinicians with extensive information on insulin function, glucose regulation, and the progression of metabolic disorders that affect long-term health outcomes.

The Glucose Tolerance Test, 4 Specimens evaluates blood glucose at fasting, 1-hour, 2-hour, and 3-hour intervals after a glucose drink. This test is an important tool for diagnosing or screening for prediabetes, type 2 diabetes, and impaired glucose metabolism. Measuring glucose response across multiple specimens provides valuable data on insulin function, carbohydrate handling, and overall metabolic health.

The Glucose Tolerance Test, 2 Specimens, 75g evaluates the body’s glucose metabolism by testing fasting and one-hour blood glucose levels after ingestion of a 75-gram glucose solution. It is an important diagnostic tool for identifying impaired glucose regulation, prediabetes, and type 2 diabetes. This test helps reveal early changes in insulin sensitivity and overall metabolic function.

The Glucose Tolerance Test, 3 Specimens, 75g evaluates blood sugar at fasting, 1-hour, and 2-hour intervals following a 75-gram glucose drink. It is a key diagnostic tool for identifying impaired glucose regulation, prediabetes, and type 2 diabetes. Measuring glucose response at multiple times allows clinicians to assess insulin function, detect early metabolic dysfunction, and better understand progression to diabetes.

The Glucose Tolerance Test, 6 Specimens evaluates blood sugar response at fasting and hourly intervals up to 5 hours after ingestion of a glucose solution. This test provides a comprehensive assessment of glucose metabolism, helping detect impaired glucose tolerance, prediabetes, and diabetes risk. Measuring six specimens reveals detailed patterns of insulin function, metabolic regulation, and progression to chronic disease.

The Glucose Tolerance Test, 7 Specimens evaluates blood sugar at fasting and six hourly intervals after ingestion of a glucose solution, spanning 6 hours of monitoring. It is used to identify prediabetes, diabetes, and impaired glucose regulation. By analyzing seven specimens, the test reveals patterns in insulin function, metabolic regulation, and progression of abnormalities that impact long-term health.

The Gestational Glucose Tolerance Test, 3 Specimens, 75g evaluates glucose metabolism during pregnancy by testing fasting, 1-hour, and 2-hour blood glucose following a 75-gram glucose solution. It is widely used to diagnose gestational diabetes and assess maternal insulin function. Monitoring three intervals provides clinicians with essential information about pregnancy-related metabolic health and risk factors.

The Gestational Glucose Tolerance Test, 4 Specimens, 100g evaluates maternal blood sugar response at fasting, 1, 2, and 3 hours following a 100-gram glucose drink. It is widely used to detect gestational diabetes and impaired glucose regulation in pregnancy. By assessing four time points, the test delivers valuable data on insulin activity, maternal metabolism, and risks that may affect both mother and baby.

The Postprandial Glucose Tolerance Test, 1-Hour evaluates blood glucose response one hour after eating or consuming a glucose solution. This test is commonly used to detect abnormal post-meal glucose regulation, prediabetes, and diabetes risk. Measuring the body’s ability to manage glucose following food intake offers important data on insulin function, carbohydrate handling, and metabolic balance.

The Postprandial Glucose Tolerance Test, 2-Hour evaluates glucose response two hours after eating or consuming a glucose solution. It is an important diagnostic tool for detecting abnormal post-meal glucose regulation, prediabetes, and diabetes risk. Measuring the body’s glucose clearance at this critical interval highlights insulin function, carbohydrate handling, and early metabolic dysfunction.

 The Diabetes Prevention Program (DPP) Screening Panel is a critical tool in the early identification and management of prediabetes and diabetes. This panel utilizes targeted tests to evaluate an individual's blood sugar levels and their body's ability to process glucose over time. By accurately assessing these factors, the panel helps healthcare providers detect early signs of glycemic control issues, enabling timely intervention that can prevent the onset of diabetes or manage it effectively in its initial stages.

The Advanced Blood Sugar Monitoring - Advanced panel provides an in-depth analysis of blood sugar regulation, insulin function, and potential autoimmune aspects of diabetes. This comprehensive panel includes Adiponectin, a 4 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, and a 4 Specimens Insulin Response to Glucose test.

The Advanced Blood Sugar Monitoring - Comprehensive panel is the most extensive assessment in the series, designed to provide a detailed analysis of glucose metabolism, insulin sensitivity, and autoimmune diabetes indicators. It includes Adiponectin, a 5 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, IA-2 Antibody, a 4 Specimens Insulin Response to Glucose, and Proinsulin tests.

The Advanced Blood Sugar Monitoring - Basic Plus panel offers a more detailed look into blood sugar regulation and potential autoimmune aspects of diabetes. It includes the 3 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, and 3 Specimens Insulin Response to Glucose, providing a comprehensive evaluation of glucose metabolism and insulin function.

 The DH-4 Diabetes Health panel is a comprehensive suite of tests tailored for individuals with diabetes, particularly those with complex management needs or those at high risk for complications. This panel includes C-Reactive Protein (CRP), CBC with Differential and Platelets, Comprehensive Metabolic Panel (CMP), 2 Specimen Glucose Tolerance Test, Hemoglobin A1c, Insulin, 2 Specimen Insulin Response to Glucose, Lipid Panel, and Random Urine Microalbumin with Creatinine. It is designed to provide a thorough assessment of diabetes control, cardiovascular risk, insulin function, kidney health, and overall metabolic status.

The Diabetes & Insulin Resistance Tests Part 1 panel includes 9 tests and 71 biomarkers to help evaluate blood sugar control, insulin response, glucose tolerance, inflammation, cholesterol patterns, kidney risk, blood cell health, and overall metabolic function. This panel may help identify early patterns linked to insulin resistance, prediabetes, diabetes risk, cardiometabolic imbalance, and kidney stress.

The Advanced Blood Sugar Monitoring - Basic panel is designed to provide fundamental insights into an individual's glucose metabolism and overall blood sugar control. This panel includes two essential tests: Glucose and Hemoglobin A1c, making it an invaluable tool for initial diabetes screening and monitoring.

 The 2 Hour Fasting and Postprandial Glucose Test is a diagnostic procedure that measures the body's ability to metabolize glucose (sugar) and respond to insulin. It involves taking two blood samples: one after an overnight fast and another two hours after consuming a meal.

 The DH-1 Diabetes Health panel is specifically curated to provide a foundational assessment of an individual's diabetes status and metabolic health. It includes two essential tests: the Comprehensive Metabolic Panel (CMP) and the Hemoglobin A1c (HbA1c). This panel is designed to give a snapshot of the current glucose control and the body's metabolic state, offering crucial insights for managing diabetes effectively.